Insider Trading & Ownership of Douglas S. Ingram

Location
Irvine, CA
Summary
The estimated net worth of Douglas S. Ingram is at least $18,598,434 dollars as of 18 Dec 2025. Douglas S. Ingram is the Chief Executive Officer, Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $16.73M. Douglas S. Ingram is the Director of ARROWHEAD PHARMACEUTICALS, INC. and owns shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) stock worth about $1.87M.
Signature
/s/Doug Ingram
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Douglas S. Ingram and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Douglas S. Ingram has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $18,598,434.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Sarepta Therapeutics, Inc. ($16,729,038).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Douglas S. Ingram

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. Chief Executive Officer, Director $16,729,038 07 Dec 2025
ARWR ARROWHEAD PHARMACEUTICALS, INC. Director $1,869,396 16 Dec 2025
RLAY Relay Therapeutics, Inc. Director 06 Jun 2025

Insider Transactions Reported by Douglas S. Ingram:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .